Skip to content

Odyssey Therapeutics, Inc.

ODTX· NasdaqCore metricsCIK 1882782

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -3.68%
Market cap
$969.53M
48.07M shares
Filings
72
$0.00
Q3 2026
—
-$53.06M
Q3 2026
—
-$56.67M
Q3 2026
—
-$117.92M
Q3 2026derived
—
-$1.10
Q3 2026
—
$80.64M
Q3 2026−33.1% FY25 yoy
$969.53M
—
—
2.6×
—
—

FY2026 figures · derived

Price

$20.17+22.84%+$3.75since May 8, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00Q3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Biological products, except diagnostic substances

Odyssey Therapeutics, Inc. is the 46th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Odyssey Therapeutics, Inc. · CIK 1882782 · Engraved from SEC EDGAR